UTAH MEDICAL PRODUCTS INC
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $15.5M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $371.0K | 2.4% |
| Dividends Paid | $4.0M | 25.7% |
| Stock Repurchases | $8.4M | 53.9% |
| Net Cash Flow | $2.8M | 17.9% |